Suryapranata F S T, Prins M, Sonder G J B
Department of Infectious Diseases, Public Health Service (GGD) of Amsterdam, Nieuwe Achtergracht 100, PO Box 2200, 1000 CE, Amsterdam, The Netherlands.
National Coordination Centre for Travellers' Health Advice (LCR), Nieuwe Achtergracht 100, PO Box 1008, 1000 BA, Amsterdam, The Netherlands.
BMC Infect Dis. 2016 Dec 1;16(1):731. doi: 10.1186/s12879-016-2059-0.
Typhoid fever mainly occurs in (sub) tropical regions where sanitary conditions remain poor. In other regions it occurs mainly among returning travelers or their direct contacts. The aim of this study was to evaluate the current Dutch guidelines for typhoid vaccination.
Crude annual attack rates (AR) per 100,000 Dutch travelers were calculated during the period 1997 to 2014 by dividing the number of typhoid fever cases by the estimated total number of travelers to a specific country or region. Regions of exposure and possible risk factors were evaluated.
During the study period 607 cases of typhoid fever were reported. Most cases were imported from Asia (60%). Almost half of the cases were ethnically related to typhoid risk regions and 37% were cases visiting friends and relatives. The overall ARs for travelers to all regions declined significantly. Countries with the highest ARs were India (29 per 100,000), Indonesia (8 per 100,000), and Morocco (10 per 100,000). There was a significant decline in ARs among travelers to popular travel destinations such as Morocco, Turkey, and Indonesia. ARs among travelers to intermediate-risk areas according to the Dutch guidelines such as Latin America or Sub-Saharan Africa remained very low, despite the restricted vaccination policy for these areas compared to many other guidelines.
The overall AR of typhoid fever among travelers returning to the Netherlands is very low and has declined in the past 20 years. The Dutch vaccination policy not to vaccinate short-term travelers to Latin-America, Sub-Saharan Africa, Thailand and Malaysia seems to be justified, because the ARs for these destinations remain very low. These results suggest that further restriction of the Dutch vaccination policy is justified.
伤寒热主要发生在卫生条件仍然较差的(亚)热带地区。在其他地区,它主要发生在回国旅行者或其直接接触者中。本研究的目的是评估荷兰目前的伤寒疫苗接种指南。
通过将伤寒热病例数除以前往特定国家或地区的旅行者估计总数,计算1997年至2014年期间每10万荷兰旅行者的粗年发病率(AR)。评估暴露地区和可能的风险因素。
在研究期间,报告了607例伤寒热病例。大多数病例是从亚洲输入的(60%)。几乎一半的病例在种族上与伤寒风险地区有关,37%是探亲访友的病例。前往所有地区的旅行者的总体ARs显著下降。ARs最高的国家是印度(每10万中有29例)、印度尼西亚(每10万中有8例)和摩洛哥(每10万中有10例)。前往摩洛哥、土耳其和印度尼西亚等热门旅游目的地的旅行者的ARs显著下降。根据荷兰指南属于中等风险地区的拉丁美洲或撒哈拉以南非洲等地区旅行者的ARs仍然很低,尽管与许多其他指南相比,这些地区的疫苗接种政策受到限制。
返回荷兰的旅行者中伤寒热的总体AR非常低,并且在过去20年中有所下降。荷兰不对前往拉丁美洲、撒哈拉以南非洲、泰国和马来西亚的短期旅行者进行疫苗接种的政策似乎是合理的,因为这些目的地的ARs仍然很低。这些结果表明,进一步限制荷兰的疫苗接种政策是合理的。